SCHEMBL190942

SCHEMBL190942

c1ccc2cc3c(cc2c1)c1cc2ccccc2cc1c1cc2ccccc2cc31

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
HSD17B10 Q99714 5/20 0.56
HIF1A Q16665 3/20 0.56
CYP1B1 Q16678 1/20 0.56
CYP2A6 P11509 6/20 0.54
ALOX12 P18054 1/20 0.54
NQO1 P15559 1/20 0.52
TDP1 Q9NUW8 3/20 0.50
TSHR P16473 2/20 0.50
NQO2 P16083 1/20 0.47
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
HPRT1 P00492 2/20 0.44
CASP1 P29466 2/20 0.43
CASP7 P55210 2/20 0.43
HPGD P15428 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28463321 1.00 ALDH1A1 (0.56) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
SCHEMBL29423353 1.00 ALDH1A1 (0.56) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
Anthracene SCHEMBL28787108 0.96 ALDH1A1 (0.53) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
Benzene SCHEMBL4881895 0.96 ALDH1A1 (0.53) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
Benzo[B]Triphenylene SCHEMBL29374595 0.93 ALDH1A1 (0.58) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
SCHEMBL4855544 0.93 ALDH1A1 (0.58) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
Benzo[B]Triphenylene SCHEMBL29628013 0.93 ALDH1A1 (0.58) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
Benzo[B]Triphenylene SCHEMBL71635 0.93 ALDH1A1 (0.58) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
SCHEMBL415471 0.89 ALDH1A1 (0.55) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6
Benzo[B]Triphenylene SCHEMBL17537048 0.89 ALDH1A1 (0.55) ALDH1A1HSD17B10HIF1ACYP1B1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 874 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250243224-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2025-07-31 US claimed
US-12060344-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2024-08-13 US claimed
EP-3674290-B1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG ELECTRONICS CO LTD (KR) 2024-05-22 EP claimed
WO-2024029292-A1 COMPOSITION, COMPOUND, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE JSR株式会社 2024-02-08 WO claimed
EP-3994207-B1 HNBR VULCANISATES CONTAINING POLYCYCLIC AROMATIC HYDROCARBONS ARLANXEO DEUTSCHLAND GMBH (DE) 2023-08-09 EP claimed
CN-116075292-A Method and composition for tinting a keratinous substrate using a soluble vat dye 威娜德国有限责任公司 2023-05-05 CN claimed
US-20230140682-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO LTD (KR) 2023-05-04 US claimed
EP-4174054-A1 HETEROCYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND Samsung Electronics Co., Ltd. (KR) 2023-05-03 EP claimed
US-11542252-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-01-03 US claimed
US-20220372255-A1 HNBR vulcanisates containing polycyclic aromatic hydrocarbons ARLANXEO DEUTSCHLAND GMBH (DE) 2022-11-24 US claimed
WO-2009109781-A2 POLYCYCLIC ORGANIC COMPOUNDS, POLARIZING ELEMENTS AND METHOD OF PRODUCTION THEREOF CRYSOPTIX K.K. (JP) 2009-09-11 WO claimed
US-20080213624-A1 ORGANIC ELECTRONIC DEVICE E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-09-04 US claimed
WO-2008106210-A1 ORGANIC ELECTRONIC DEVICE E. I. DU PONT DE NEMOURS AND COMPANY (US) 2008-09-04 WO claimed
US-20080124455-A1 ORGANIC LIGHT EMITTING COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-05-29 US claimed
US-20080100208-A1 ORGANIC LIGHT-EMITTING COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-05-01 US claimed
CN-101100452-A Dimethylenecyclohexane compound, method of preparing the same and organic light emitting device comprising the dimethylenecyclohexane compound SAMSUNG SDI CO LTD (KR) 2008-01-09 CN claimed
US-20070255076-A1 Method for Deuteration of an Aromatic Ring WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2007-11-01 US claimed
CN-1296331-C Method for deuteration of aromatic ring WAKO PURE CHEM IND LTD (JP) 2007-01-24 CN claimed
CN-1675145-A Method of deuterating aromatic ring WAKO PURE CHEM IND LTD (JP) 2005-09-28 CN claimed
EP-1535889-A1 METHOD OF DEUTERATING AROMATIC RING Wako Pure Chemical Industries, Ltd. (JP) 2005-06-01 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542252-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 ALDH1A1 172/4885HSD17B10 2320/4885HIF1A 2323/4885
US-20230140682-A1 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 ALDH1A1 172/4885HSD17B10 2320/4885HIF1A 2323/4885
US-20080124455-A1 ORGANIC LIGHT EMITTING COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT EMITTING DEVICE CYBA, CRY2, CRY1 ALDH1A1 322/4885HSD17B10 1289/4885HIF1A 3743/4885
US-20070255076-A1 Method for Deuteration of an Aromatic Ring HRH3, HRH4, AHR ALDH1A1 2654/4885HSD17B10 349/4885HIF1A 1931/4885
US-20080100208-A1 ORGANIC LIGHT-EMITTING COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE COMPOUND, AND METHOD OF MANUFACTURING THE ORGANIC LIGHT-EMITTING DEVICE C1R, CYBA, LAS1L ALDH1A1 311/4885HSD17B10 3401/4885HIF1A 4293/4885
US-20250243224-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE ARL1, RIF1, RER1 ALDH1A1 706/4885HSD17B10 2396/4885HIF1A 3535/4885
US-12060344-B2 Heterocyclic compound, composition including the same, and organic light-emitting device including the heterocyclic compound CCNT1, CCNA1, CYP1B1 ALDH1A1 172/4885HSD17B10 2320/4885HIF1A 2323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.